PQRS Measure
Report via: Claim, Registry
The following codes apply for this PQRS measure:
CPT Codes | |||
| Code | Modifier | POS | Description |
|---|---|---|---|
| 88360 | Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manual | ||
| 88361 | Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; using computer-assisted technology | ||
| 3394F | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) | ||
| 3394F | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) | ||
| 3394F | 8P | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) | |
| 3394F | 8P | Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring system defined in the ASCO/CAP guidelines (PATH) | |
| 3395F | Quantitative non-HER2 immunohistochemistry (IHC) evaluation of breast cancer (eg, testing for estrogen or progesterone receptors [ER/PR]) performed (PATH) | ||
ICD10CM Codes | |||
| Code | Modifier | POS | Description |
| C50.011 | Malignant neoplasm of nipple and areola, right female breast | ||
| C50.012 | Malignant neoplasm of nipple and areola, left female breast | ||
| C50.019 | Malignant neoplasm of nipple and areola, unspecified female breast | ||
| C50.021 | Malignant neoplasm of nipple and areola, right male breast | ||
| C50.022 | Malignant neoplasm of nipple and areola, left male breast | ||
| C50.029 | Malignant neoplasm of nipple and areola, unspecified male breast | ||
| C50.111 | Malignant neoplasm of central portion of right female breast | ||
| C50.112 | Malignant neoplasm of central portion of left female breast | ||
| C50.119 | Malignant neoplasm of central portion of unspecified female breast | ||
| C50.121 | Malignant neoplasm of central portion of right male breast | ||
| C50.122 | Malignant neoplasm of central portion of left male breast | ||
| C50.129 | Malignant neoplasm of central portion of unspecified male breast | ||
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast | ||
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast | ||
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast | ||
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast | ||
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast | ||
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast | ||
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast | ||
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast | ||
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast | ||
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast | ||
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast | ||
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast | ||
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast | ||
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast | ||
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast | ||
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast | ||
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast | ||
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast | ||
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast | ||
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast | ||
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast | ||
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast | ||
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast | ||
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast | ||
| C50.611 | Malignant neoplasm of axillary tail of right female breast | ||
| C50.612 | Malignant neoplasm of axillary tail of left female breast | ||
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast | ||
| C50.621 | Malignant neoplasm of axillary tail of right male breast | ||
| C50.622 | Malignant neoplasm of axillary tail of left male breast | ||
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast | ||
| C50.811 | Malignant neoplasm of overlapping sites of right female breast | ||
| C50.812 | Malignant neoplasm of overlapping sites of left female breast | ||
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast | ||
| C50.821 | Malignant neoplasm of overlapping sites of right male breast | ||
| C50.822 | Malignant neoplasm of overlapping sites of left male breast | ||
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast | ||
| C50.911 | Malignant neoplasm of unspecified site of right female breast | ||
| C50.912 | Malignant neoplasm of unspecified site of left female breast | ||
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast | ||
| C50.921 | Malignant neoplasm of unspecified site of right male breast | ||
| C50.922 | Malignant neoplasm of unspecified site of left male breast | ||
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast | ||
Legend:
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPROThis measure can be submitted via Group Practice Reporting Option, or GPRO Web Interface.
SurveyThis measure can be submitted/collected via a Certified Survey Vendor.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPROThis measure can be submitted via Group Practice Reporting Option, or GPRO Web Interface.
SurveyThis measure can be submitted/collected via a Certified Survey Vendor.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com